BACKGROUND: There are currently an estimated 250,000 female cancer survivors of reproductive age living in the US. Loss of fertility is an issue many cancer survivors face after treatment, as all forms of cancer therapy can cause infertility. Methods to preserve fertility can be initiated prior to cancer therapy. These methods include embryo cryopreservation, oocyte cryopreservation, fertility sparing surgery, ovarian tissue cryopreservation, ovarian transposition, and medical therapy. LITERATURE REVIEW: Although the clinical guidelines state that oncologists should discuss the risk of infertility with every patient of reproductive age and should refer every patient who is interested in or ambivalent towards fertility preservation to reproductive endocrinologists, studies have shown that a significant proportion of female cancer patients report never receiving information about fertility. Even fewer female cancer patients are referred to reproductive endocrinologists for further discussion and/or potential treatment. PROPOSED PROJECT: Oncologists at Boston Medical Center will be recruited to participate in a study that measures the effect of an educational intervention on referral rate to reproductive endocrinology. The knowledge gained from the intervention will be assessed with a pre- and post-test. The proportion of female patients age 18-45 referred to reproductive endocrinology will be evaluated through the Electronic Medical Record System. The correlation between knowledge gain and change in referral rates will also be assessed. CONCLUSION: Fertility after cancer treatment is an essential issue to consider for young cancer survivors. These patients benefit from being referred to reproductive endocrinologists so that they can get information about fertility preservation and undergo treatment in a timely fashion. Improving and/or reinforcing oncologist knowledge about this topic will increase the rate at which they initiate this conversation and therefore the number of female patients who are referred to reproductive endocrinology. SIGNIFICANCE: Providing female cancer patients with information about and opportunities to undergo fertility preservation will maximize their options. This will lead to a higher quality of life after cancer therapy.

La conservation de la biodiversité génétique du cochon d’Inde (Cavia porcellus) est importante en tant qu’animal de consommation endémique de la région andine ainsi qu’en tant qu’animal modèle précieux pour la recherche biomédicale.L’objectif de ce travail était de mettre en place les protocoles qui permettront une conservation ex situ des ressources génétiques de cette espèce par la voie femelle. Les étapes nécessaires à la concrétisation d’un projet de cryobanque sont :- la maîtrise de la production d’embryons grâce à des traitements hormonaux de synchronisation du cycle œstral et de superovulation des femelles,- la cryoconservation dans l’azote liquide des embryons obtenus et leur transfert dans des femelles receveuses.Une méthode standardisée de synchronisation des chaleurs basée sur l’administration d’altrenogest per os pendant 15 jours a été définie. Les chaleurs des femelles donneuses et receveuses d’embryons apparaissent dans les 4 à 5 jours qui suivent l’arrêt du traitement de ce progestagène.Des traitements de superovulation basés sur 3 injections à 24 heures d’intervalle d’hMG, ou 6 injections à 12 heures d’intervalle de FSH-recombinante humaine, permettent une augmentation du taux d’ovulation de l’ordre de fois 3 à fois 4 par rapport à des femelles non-traitées. Toutefois les réponses au traitement restent variables et il faudra réitérer l’expérience sur de plus grands lots d’animaux afin d’ajuster les doses et les moments d’application.La méthode de congélation lente, utilisant l’éthylène glycol comme cryoprotecteur, a permis d’obtenir des taux de survie embryonnaire satisfaisants (70,3%). La méthode de vitrification a également donné de bons résultats, avec un taux de survie embryonnaire de 41,7%.Le premier transfert au monde d’embryons frais réalisé avec succès dans une femelle receveuse préalablement synchronisée a été obtenu lors de ce travail. Les transferts d’embryons décongelés n’ont pas encore donné lieu à des gestations. / The preservation of the guinea pig (Cavia porcellus) genetic biodiversity is important as a native source of protein for many highlanders in the Andean region and as a precious laboratory animal for biomedical research.The aim of this work was to establish the protocols that will enable an ex situ preservation of the genetic resources of this species by the female way.The necessary steps for the achievement of a cryobank project are:- the control of the embryo production thanks to hormonal treatments to synchronize the estrous cycles and to superovulate the females,- the cryopreservation in liquid nitrogen of the obtained embryos and their transfer into recipient females.A standard method for synchronization of heat periods based on the per os administration of altrenogest during 15 days has been defined. The heat periods of the females, donors and recipients of embryos, appears 4 to 5 days after the end of the progestagen treatment. Superovulation treatments, based on 3 injections at 24-hour intervals of hMG or 6 injections at 12-hour intervals of human recombinant-FSH, lead to an increase of the ovulation rate of about 3 to 4 times when compared to untreated females. However, the responses to the treatments remain variable and further studies involving a larger number of animals should be carried out in order to adjust the dose and the moment of application of the treatment.The slow-freezing method, using ethylene glycol as cryoprotectant, enables the attainment of a satisfactory in vitro embryo survival rate (70,3%). The vitrification method also gives good results, with a 41,7% in vitro embryo survival rate.The first successful transfer of fresh embryos into a synchronized recipient female has been achieved in this study. The transfers of frozen-thawed embryos did not yet lead to gestation.